1. Home
  2. NEXT vs RAPP Comparison

NEXT vs RAPP Comparison

Compare NEXT & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

N/A

Current Price

$5.77

Market Cap

1.5B

Sector

Energy

ML Signal

N/A

RAPP

Rapport Therapeutics Inc.

N/A

Current Price

$30.13

Market Cap

1.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NEXT
RAPP
Founded
2010
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
NEXT
RAPP
Price
$5.77
$30.13
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$7.50
$47.00
AVG Volume (30 Days)
2.8M
266.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
83.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$7.73
52 Week High
$12.12
$42.27

Technical Indicators

Market Signals
Indicator
NEXT
RAPP
Relative Strength Index (RSI) 57.31 57.81
Support Level $5.58 $24.45
Resistance Level $6.35 $42.27
Average True Range (ATR) 0.37 2.09
MACD 0.04 0.07
Stochastic Oscillator 45.56 72.71

Price Performance

Historical Comparison
NEXT
RAPP

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: